CATENIBACTERIUM MITSUOKAI PROMOTES TUMOR IMMUNOSUPPRESSION THROUGH METABOLIC REPROGRAMMING OF PMN-MDSC IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Guan, Huayu
Zhao, Yutong
Ren, Xuxin
Yang, Qingxia
Li, Shangru
Zheng, Gaomin
Peng, Sui
Kuang, Ming
Zhang, Ying
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1526
引用
收藏
页码：S1569 / S1570
页数：2
相关论文
共 50 条
  • [11] Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells
    Cao, Ting-Ting
    Lin, Shu-Hai
    Fu, Li
    Tang, Zhi
    Che, Chi-Ming
    Zhang, Li-Yi
    Ming, Xiao-Yan
    Liu, Teng-Fei
    Tang, Xu-Ming
    Tan, Bin-Bin
    Xiang, Di
    Li, Feng
    Chan, On-Yee
    Xie, Dan
    Cai, Zongwei
    Guan, Xin-Yuan
    CARCINOGENESIS, 2017, 38 (01) : 94 - 104
  • [12] Targeting the Warburg effect prevents cancer metabolic reprogramming in hepatocellular carcinoma cells and promotes cell death.
    Cassim, Shamir
    Raymond, Valerie-Ann
    Bilodeau, Marc
    HEPATOLOGY, 2017, 66 : 988A - 988A
  • [13] Sodium borate treatment induces metabolic reprogramming in hepatocellular carcinoma through SIRT3 activation
    Ustuner, Berna
    Cimen, Huseyin
    TURKISH JOURNAL OF BIOLOGY, 2016, 40 (04) : 906 - 914
  • [14] Tumor-infiltrating PMN-MDSCs mediate sorafenib resistance in hepatocellular carcinoma through immune suppression
    Chang, Chun-Jung
    Lu, Li-Chun
    Liang, Cher-wei
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    CANCER RESEARCH, 2017, 77
  • [15] p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
    Saito, Tetsuya
    Ichimura, Yoshinobu
    Taguchi, Keiko
    Suzuki, Takafumi
    Mizushima, Tsunehiro
    Takagi, Kenji
    Hirose, Yuki
    Nagahashi, Masayuki
    Iso, Tetsuro
    Fukutomi, Toshiaki
    Ohishi, Maki
    Endo, Keiko
    Uemura, Takefumi
    Nishito, Yasumasa
    Okuda, Shujiro
    Obata, Miki
    Kouno, Tsuguka
    Imamura, Riyo
    Tada, Yukio
    Obata, Rika
    Yasuda, Daisuke
    Takahashi, Kyoko
    Fujimura, Tsutomu
    Pi, Jingbo
    Lee, Myung-Shik
    Ueno, Takashi
    Ohe, Tomoyuki
    Mashino, Tadahiko
    Wakai, Toshifumi
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Nagano, Tetsuo
    Motohashi, Hozumi
    Waguri, Satoshi
    Soga, Tomoyoshi
    Yamamoto, Masayuki
    Tanaka, Keiji
    Komatsu, Masaaki
    NATURE COMMUNICATIONS, 2016, 7
  • [16] p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
    Tetsuya Saito
    Yoshinobu Ichimura
    Keiko Taguchi
    Takafumi Suzuki
    Tsunehiro Mizushima
    Kenji Takagi
    Yuki Hirose
    Masayuki Nagahashi
    Tetsuro Iso
    Toshiaki Fukutomi
    Maki Ohishi
    Keiko Endo
    Takefumi Uemura
    Yasumasa Nishito
    Shujiro Okuda
    Miki Obata
    Tsuguka Kouno
    Riyo Imamura
    Yukio Tada
    Rika Obata
    Daisuke Yasuda
    Kyoko Takahashi
    Tsutomu Fujimura
    Jingbo Pi
    Myung-Shik Lee
    Takashi Ueno
    Tomoyuki Ohe
    Tadahiko Mashino
    Toshifumi Wakai
    Hirotatsu Kojima
    Takayoshi Okabe
    Tetsuo Nagano
    Hozumi Motohashi
    Satoshi Waguri
    Tomoyoshi Soga
    Masayuki Yamamoto
    Keiji Tanaka
    Masaaki Komatsu
    Nature Communications, 7
  • [17] Metabolic reprogramming through Notch1 signaling promotes a survival advantage in pancreatic neuroendocrine tumor cells
    Guenter, Rachael
    Chen, Weisheng
    Herring, Brendon
    Golivi, Yuvasri
    Sammy, Melissa
    Whitt, Jason
    Jaskula-Sztul, Renata
    Chen, Herbert
    Rose, J. Bart
    CANCER RESEARCH, 2024, 84 (06)
  • [18] The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine
    Shi, Xiaoyan
    Zhang, Yangyi
    Wang, Yuci
    Wang, Jie
    Gao, Yang
    Wang, Ruiqi
    Wang, Liyong
    Xiong, Minggang
    Cao, Yanlan
    Ou, Ningjing
    Liu, Qi
    Ma, Honghui
    Cai, Jiabin
    Chen, Hao
    CELL DEATH AND DIFFERENTIATION, 2024, 31 (09): : 1219 - 1234
  • [19] lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPAR pathway in hepatocellular carcinoma
    Li, Xiao
    Zhao, Qi
    Qi, Jianni
    Wang, Wenwen
    Zhang, Di
    Li, Zhen
    Qin, Chengyong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (02) : 551 - 566
  • [20] GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma
    Li, Luhao
    Li, Suxin
    Wang, Haohao
    Li, Lin
    Wang, Peiju
    Shen, Dongqi
    Dang, Xiaowei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 625 : 109 - 115
12345